Literature DB >> 4890826

Azathioprine in active chronic iridocyclitis. A double-blind controlled trial.

J D Mathews, B A Crawford, J L Bignell, I R Mackay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4890826      PMCID： PMC1207364          DOI： 10.1136/bjo.53.5.327

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  4 in total

Review 1.  Recent advances in the study of uveitis.

Authors:  E S Perkins
Journal:  Br J Ophthalmol       Date:  1974-04       Impact factor: 4.638

Review 2.  Emerging drugs for uveitis.

Authors:  Theresa Larson; Robert B Nussenblatt; H Nida Sen
Journal:  Expert Opin Emerg Drugs       Date:  2011-01-06       Impact factor: 4.191

3.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

4.  Azathioprine for ocular inflammatory diseases.

Authors:  Sirichai Pasadhika; John H Kempen; Craig W Newcomb; Teresa L Liesegang; Siddharth S Pujari; James T Rosenbaum; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; Eric B Suhler
Journal:  Am J Ophthalmol       Date:  2009-07-01       Impact factor: 5.258
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.